Mesoblast (MESO) Depreciation & Amortization (CF) (2016 - 2023)

Mesoblast (MESO) reported Depreciation & Amortization (CF) of -$991000.0 for Q1 2023, up 11.04% on a YoY basis from -$892460.8 in Q1 2022, and up 8.83% sequentially from -$1.1 million in Q4 2022.

Mesoblast (MESO) Depreciation & Amortization (CF) (2016 - 2023) Analysis & Trends

Mesoblast (MESO) has 8 years of Depreciation & Amortization (CF) data on file, last reported at -$991000.0 in Q1 2023.

  • For the quarter ending Q1 2023, Depreciation & Amortization (CF) rose 11.04% year-over-year to -$991000.0; the trailing twelve-month figure through Jun 2024 stood at -$991000.0 (up 68.87% YoY), and the FY2017 full-year result was -$3.1 million, changed N/A from the prior year.
  • Depreciation & Amortization (CF) rose to -$991000.0 in Q1 2023, from -$1.1 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $3.1 million in Q4 2020 to a low of -$1.1 million in Q1 2022.
  • A 5-year average of -$515538.5 and a median of -$991000.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
  • Across the five-year window, Depreciation & Amortization (CF) slumped 253.25% in 2019 and surged 453.41% in 2020, its largest moves.
  • Tracing MESO's Depreciation & Amortization (CF) over 5 years: stood at -$865000.0 in 2019, then surged by 453.41% to $3.1 million in 2020, then sank by 136.05% to -$1.1 million in 2021, then grew by 1.36% to -$1.1 million in 2022, then increased by 8.83% to -$991000.0 in 2023.
  • Business Quant data shows MESO's Depreciation & Amortization (CF) at -$991000.0 in Q1 2023, -$1.1 million in Q4 2022, and -$1.1 million in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 196,658.72
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 41.14 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 55.90 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 123.20 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 2.20 Mn
10 Mesoblast 19.81 Bn 19.68 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2023 -991,000.00
Mar 31, 2023 -991,000.00
Dec 31, 2022 -1.09 Mn
Dec 31, 2022 -1.09 Mn
Sep 30, 2022 -1.11 Mn
Sep 30, 2022 -1.11 Mn
Mar 31, 2022 -1.11 Mn
Mar 31, 2022 -1.11 Mn
Dec 31, 2021 -1.10 Mn
Dec 31, 2021 -1.10 Mn
Sep 30, 2021 -1.09 Mn
Sep 30, 2021 -1.09 Mn
Mar 31, 2021 -1.08 Mn
Mar 31, 2021 -1.08 Mn
Dec 31, 2020 3.06 Mn
Dec 31, 2020 3.06 Mn
Sep 30, 2020 1.01 Mn
Sep 30, 2020 1.01 Mn
Mar 31, 2020 -945,000.00
Mar 31, 2020 -945,000.00